Skandinaviska Enskilda Banken (SEB) Portfolio holdings
AUM
$23B
1-Year Return
23.43%
This Quarter Return
-2.44%
1 Year Return
+23.43%
3 Year Return
+116.09%
5 Year Return
+203.29%
10 Year Return
–
AUM
$15.2B
AUM Growth
-$13.2M
(-0.09%)
Cap. Flow
+$557M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
1,018
New
74
Increased
253
Reduced
520
Closed
91
Top Buys
| 1 |
Microsoft
MSFT
|
$341M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$174M |
| 3 |
Amazon
AMZN
|
$96.4M |
| 4 |
Applied Materials
AMAT
|
$69.4M |
| 5 |
AbbVie
ABBV
|
$54.2M |
Top Sells
| 1 |
Apple
AAPL
|
$51M |
| 2 |
NVIDIA
NVDA
|
$38.6M |
| 3 |
Ryder
R
|
$31.7M |
| 4 |
Merck
MRK
|
$30.8M |
| 5 |
Johnson & Johnson
JNJ
|
$29.9M |
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Healthcare | 18.7% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Kirby Corp
KEX
$4.97B
| $555K | ﹤0.01% |
6,700
+2,100
| +46% | +$174K |
|
752
Nicolet Bankshares
NIC
$2.02B
| $555K | ﹤0.01% |
7,950
-1,600
| -17% | -$112K |
|
753
Korn Ferry
KFY
$3.83B
| $546K | ﹤0.01% |
11,500
-2,300
| -17% | -$109K |
|
754
Pacific Biosciences
PACB
$381M
| $544K | ﹤0.01% |
65,200
-13,400
| -17% | -$112K |
|
755
Shoals Technologies Group
SHLS
$1.2B
| $542K | ﹤0.01% |
29,700
-600
| -2% | -$10.9K |
|
756
ePlus
PLUS
$1.89B
| $534K | ﹤0.01% |
8,400
-1,700
| -17% | -$108K |
|
757
AvePoint
AVPT
$3.45B
| $532K | ﹤0.01% |
+79,100
| New | +$532K |
|
758
Stepan Co
SCL
$1.13B
| $532K | ﹤0.01% |
7,100
-1,400
| -16% | -$105K |
|
759
IDEAYA Biosciences
IDYA
$2.38B
| $529K | ﹤0.01% |
19,611
| – | – |
|
760
SPS Commerce
SPSC
$4.19B
| $529K | ﹤0.01% |
3,100
-600
| -16% | -$102K |
|
761
Ziff Davis
ZD
$1.56B
| $529K | ﹤0.01% |
8,300
+200
| +2% | +$12.7K |
|
762
Axcelis
ACLS
$2.53B
| $522K | ﹤0.01% |
3,200
-100
| -3% | -$16.3K |
|
763
CarGurus
CARG
$3.59B
| $520K | ﹤0.01% |
29,700
+5,700
| +24% | +$99.8K |
|
764
Revolution Medicines
RVMD
$7.57B
| $519K | ﹤0.01% |
+18,767
| New | +$519K |
|
765
Sylvamo
SLVM
$1.83B
| $519K | ﹤0.01% |
11,800
+5,800
| +97% | +$255K |
|
766
Legend Biotech
LEGN
$6.66B
| $517K | ﹤0.01% |
7,700
| – | – |
|
767
Greif
GEF
$3.57B
| $514K | ﹤0.01% |
7,700
-1,600
| -17% | -$107K |
|
768
Yext
YEXT
$1.1B
| $509K | ﹤0.01% |
80,400
-16,500
| -17% | -$104K |
|
769
Amphastar Pharmaceuticals
AMPH
$1.37B
| $506K | ﹤0.01% |
11,000
-2,200
| -17% | -$101K |
|
770
STAAR Surgical
STAA
$1.38B
| $482K | ﹤0.01% |
12,000
-2,400
| -17% | -$96.4K |
|
771
Alignment Healthcare
ALHC
$3.14B
| $480K | ﹤0.01% |
69,100
-14,100
| -17% | -$97.9K |
|
772
Enterprise Financial Services Corp
EFSC
$2.24B
| $480K | ﹤0.01% |
12,800
-2,600
| -17% | -$97.5K |
|
|
AVID
773
DELISTED
Avid Technology Inc
AVID
| $468K | ﹤0.01% |
17,400
-3,500
| -17% | -$94.1K |
|
774
Baker Hughes
BKR
$44.9B
| $465K | ﹤0.01% |
13,174
-35,086
| -73% | -$1.24M |
|
775
Seadrill
SDRL
$2.04B
| $458K | ﹤0.01% |
10,219
-11,190
| -52% | -$502K |
|